ResMed | RMD - Ordinary Share Capital


ResMed reported $145.97M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Ansell USD 1.03B 305.2M Jun/2024
AtriCure USD 49.7M 10K Sep/2025
Baxter International USD 514.28M 168.72M Dec/2025
Cochlear AUD 1.18B 19.2M Dec/2024
Cooper Companies USD 198.81M 9K Sep/2025
CSL USD 576M 19M Dec/2024
Dexcom USD 384.8M 5.2M Dec/2025
Edwards Lifesciences USD 580.7M 7.2M Sep/2025
Fisher Paykel Healthcare NZD 587.25M 1.35M Dec/2025
Globus Medical USD 135.05M 134.92M Jun/2025
Haemonetics USD 46.83M 82K Dec/2025
Hologic USD 222.57M 350K Sep/2025
Idexx Laboratories USD 79.85M 154K Dec/2025
Inogen USD 23K 0 Dec/2023
Insulet USD 70.35M 1000 Dec/2025
Integra LifeSciences USD 77.92M 77M Jun/2025
Intuitive Surgical USD 354.5M 3.98M Dec/2025
Masimo USD 53.1M 1.2M Sep/2025
Medtronic USD 1.28B 116K Sep/2025
Philips EUR 951.29M 310K Dec/2025
Ramsay Health Care AUD 2.27B 19.6M Dec/2024
ResMed USD 145.97M 25K Dec/2025
Sigma Healthcare AUD 11.5B 9.93B Dec/2025
Sonic Healthcare AUD 4.15B 467K Dec/2024
Steris USD 98.15M 344K Dec/2025
Teleflex USD 44.19M 482K Jun/2025
Thermo Fisher Scientific USD 375.71M 1.9M Dec/2025